Revolutionizing Alzheimer's Disease Clinical Trials Using a Blood-Based Diagnostic Test for Participant Identification, Upcoming Webinar Hosted by Xtalks
Toronto, ON (PRWEB) August 09, 2023 -- Join this webinar to learn about a newly launched blood-based diagnostic test that has the potential to help accelerate and simplify Alzheimer’s clinical trials.
Alzheimer’s disease and other dementias are devastating neurodegenerative disorders affecting more than 55 million people worldwide and have been challenging to detect in early stages.
In this webinar, the featured speaker will explain how this new blood-based test works and the promise it holds for identifying individuals at risk of developing Alzheimer’s disease even before the onset of noticeable symptoms and irreparable brain damage occurs.
One of the significant implications of this test lies in its potential for pharmaceutical companies conducting clinical trials. By identifying suitable participants in the early stages, participation and intervention can occur sooner, allowing for more effective treatments to be developed and tested. This webinar will delve into the various ways this blood-based diagnostic test can assist pharma companies in identifying individuals who are more likely to benefit from novel therapeutic interventions.
During this webinar, esteemed Neurology expert, Dr. Michael Racke, will explore the scientific basis of the blood-based diagnostic test, its reliability and its potential impact, offering a less-invasive and more accessible tool that could transform the landscape of Alzheimer’s research.
Join this exclusive webinar and be at the forefront of the latest advancements in Alzheimer’s disease research. Discover how this blood-based diagnostic test has the power to enhance clinical trials, ushering in a new era of early intervention and hope for individuals affected by Alzheimer’s disease.
Join Dr. Michael K. Racke, MD, Medical Director, Neurology, Quest Diagnostics, for the live webinar on Thursday, August 24, 2023, at 1pm EDT (10am PDT).
For more information, or to register for this event, visit Revolutionizing Alzheimer's Disease Clinical Trials Using a Blood-Based Diagnostic Test for Participant Identification.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
Share this article